Therapeutic efficacy of artemether-lumefantrine and molecular markers of antimalarial drug resistance in Benin, 2022

This publication has 28 references indexed in Scilit:

• Increasing Prevalence of Artemisinin-Resistant HRP2-Negative Malaria in Eritrea
  New England Journal of Medicine, 2023
• Plasmodium falciparum resistant to artemisinin and diagnostics have emerged in Ethiopia
  Nature Microbiology, 2023
• Prevalence of Plasmodium falciparum haplotypes associated with resistance to sulfadoxine–pyrimethamine and amodiaquine before and after upscaling of seasonal malaria chemoprevention in seven African countries: a genomic surveillance study
  The Lancet Infectious Diseases, 2022
• Decreased susceptibility of Plasmodium falciparum to both dihydroartemisinin and lumefantrine in northern Uganda
  Nature Communications, 2022
• Evidence of Artemisinin-Resistant Malaria in Africa
  New England Journal of Medicine, 2021
• A review of the frequencies of Plasmodium falciparum Kelch 13 artemisinin resistance mutations in Africa
  International Journal for Parasitology: Drugs and Drug Resistance, 2021
• Association of Plasmodium falciparum kelch13 R561H genotypes with delayed parasite clearance in Rwanda: an open-label, single-arm, multicentre, therapeutic efficacy study
  The Lancet Infectious Diseases, 2021
• Targeted deep amplicon sequencing of antimalarial resistance markers in Plasmodium falciparum isolates from Cameroon
  International Journal of Infectious Diseases, 2021
• Spatial and molecular mapping of Pfkelch13 gene polymorphism in Africa in the era of emerging Plasmodium falciparum resistance to artemisinin: a systematic review
  The Lancet Infectious Diseases, 2021
• Molecular determinants of sulfadoxine-pyrimethamine resistance in Plasmodium falciparum in Nigeria and the regional emergence of dhps 431V
  International Journal for Parasitology: Drugs and Drug Resistance, 2016